These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Rhabdomyolysis after concomitant use of cyclosporine, simvastatin, gemfibrozil, and itraconazole. Maxa JL; Melton LB; Ogu CC; Sills MN; Limanni A Ann Pharmacother; 2002 May; 36(5):820-3. PubMed ID: 11978159 [TBL] [Abstract][Full Text] [Related]
5. Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population. Bakhai A; Rigney U; Hollis S; Emmas C Pharmacoepidemiol Drug Saf; 2012 May; 21(5):485-93. PubMed ID: 22237927 [TBL] [Abstract][Full Text] [Related]
6. Rhabdomyolysis due to probable interaction between simvastatin and ritonavir. Cheng CH; Miller C; Lowe C; Pearson VE Am J Health Syst Pharm; 2002 Apr; 59(8):728-30. PubMed ID: 11977859 [TBL] [Abstract][Full Text] [Related]
7. Effect of concomitant treatment with a CYP3A4 inhibitor and a calcium channel blocker. Yoshida M; Matsumoto T; Suzuki T; Kitamura S; Mayama T Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):70-5. PubMed ID: 17918187 [TBL] [Abstract][Full Text] [Related]
8. Simvastatin prescribing patterns before and after FDA dosing restrictions: a retrospective analysis of a large healthcare claims database. Tuchscherer RM; Nair K; Ghushchyan V; Saseen JJ Am J Cardiovasc Drugs; 2015 Feb; 15(1):27-34. PubMed ID: 25348907 [TBL] [Abstract][Full Text] [Related]
9. A neural network based virtual screening of cytochrome P450 3A4 inhibitors. Molnar L; Keseru GM Bioorg Med Chem Lett; 2002 Feb; 12(3):419-21. PubMed ID: 11814811 [TBL] [Abstract][Full Text] [Related]
10. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole. Neuvonen PJ; Kantola T; Kivistö KT Clin Pharmacol Ther; 1998 Mar; 63(3):332-41. PubMed ID: 9542477 [TBL] [Abstract][Full Text] [Related]
11. Mechanism-based inactivation of cytochrome P450 3A4 by 17 alpha-ethynylestradiol: evidence for heme destruction and covalent binding to protein. Lin HL; Kent UM; Hollenberg PF J Pharmacol Exp Ther; 2002 Apr; 301(1):160-7. PubMed ID: 11907170 [TBL] [Abstract][Full Text] [Related]
12. Simvastatin-diltiazem drug interaction resulting in rhabdomyolysis and hepatitis. Kanathur N; Mathai MG; Byrd RP; Fields CL; Roy TM Tenn Med; 2001 Sep; 94(9):339-41. PubMed ID: 11550401 [TBL] [Abstract][Full Text] [Related]
13. Rhabdomyolysis due to interaction of simvastatin with mibefradil. Schmassmann-Suhijar D; Bullingham R; Gasser R; Schmutz J; Haefeli WE Lancet; 1998 Jun; 351(9120):1929-30. PubMed ID: 9654265 [No Abstract] [Full Text] [Related]
14. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4. Spracklin DK; Thummel KE; Kharasch ED Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607 [TBL] [Abstract][Full Text] [Related]
15. Avoiding patient morbidity: Updated statin drug interactions and risks for patient harm. Finks SW; Campbell JD Nurse Pract; 2014 Nov; 39(11):45-51. PubMed ID: 25325525 [TBL] [Abstract][Full Text] [Related]
16. Elucidation of distinct ligand binding sites for cytochrome P450 3A4. Hosea NA; Miller GP; Guengerich FP Biochemistry; 2000 May; 39(20):5929-39. PubMed ID: 10821664 [TBL] [Abstract][Full Text] [Related]
17. The licorice root derived isoflavan glabridin inhibits the activities of human cytochrome P450S 3A4, 2B6, and 2C9. Kent UM; Aviram M; Rosenblat M; Hollenberg PF Drug Metab Dispos; 2002 Jun; 30(6):709-15. PubMed ID: 12019199 [TBL] [Abstract][Full Text] [Related]